Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 126, Issue 5, 2019, Pages 656-661

  de Jesus G R ^a   Sciascia, S ^b   Andrade, D ^c   Barbhaiya, M ^d   Tektonidou, M ^e   Banzato, A ^f   Pengo, V ^f   Ji, L ^g   Meroni, P L ^h   Ugarte, A ⁱ   Cohen, H ^j   Branch, D W ^k   Andreoli, L ^l   Belmont, H M ^m   Fortin, P R ⁿ   Petri, M ^o   Rodriguez, E ^p   Cervera, R ^q   Knight, J S ^r   Atsumi, T ^s   Willis, R ^t   Nascimento, I S ^c   Rosa, R ^c   Erkan, D ^d   Levy, R A ^a,u   more..

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL FOR SPECIAL SURGERY   (United States)

^e UNIVERSITY OF ATHENS   (Greece)

^f UNIVERSITY OF PADOVA   (Italy)

^g PEKING UNIVERSITY   (China)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ HOSPITAL DE CRUCES   (Spain)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^l UNIVERSITY OF BRESCIA   (Italy)

^m NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ LAVAL UNIVERSITY   (Canada)

^o JOHNS HOPKINS UNIVERSITY   (United States)

^p HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^q HOSPITAL CLÍNIC   (Spain)

^r UNIVERSITY OF MICHIGAN   (United States)

^s HOKKAIDO UNIVERSITY   (Japan)

^t University of Texas Medical Branch School of Medicine   (United States)

^u GLAXOSMITHKLINE   (United States)

more..

Author keywords

Antiphospholipid antibodies; antiphospholipid syndrome; fetal death; miscarriage; pre eclampsia; thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PERIPHERAL VEIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; THROMBOSIS; VALIDATION PROCESS; VALVULAR HEART DISEASE; VEIN THROMBOSIS; BLOOD; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); COMPLICATION; EVALUATION STUDY; FACTUAL DATABASE; IMMUNOLOGY; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATION; REGISTER;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 85055586505     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.15469     Document Type: Article

References (17)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.
2. Drozidnsky G, Hadar E, Shmueli A, Gabbay-Benziv R, Shiber S. Obstetric antiphospholipid syndrome and long term arterial thrombosis risk. J Thromb Thrombolysis 2017;44:371–5.
3. Gris J-C, Bouvier S, Molinari N, Galanaud J-P, Cochery-Nouvellon E, Mercier E, et al. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood 2012;119:2624–32.
4. Martinez-Zamora MA, Peralta S, Creus M, Tassies D, Reverter JC, Espinosa G, et al. Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study. Ann Rheum Dis 2012;71:61–6.
5. Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody–positive individuals. Arthritis Rheum 2007;56:2382–91.
6. Schreiber K, Radin M, Sciascia S. Current insights in obstetric antiphospholipid syndrome. Curr Opin Obstet Gynecol 2017;29:397–403.
7. Lefèvre G, Lambert M, Bacri J-L, Dubucquoi S, Quemeneur T, Caron C, et al. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients. Lupus 2011;20:861–5.
8. Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006;96:337–41.
9. Erkan D, Lockshin M, APS ACTION Members. APS ACTION – antiphospholipid syndrome alliance for clinical trials and international networking. Lupus 2012;21:695–8.
10. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. GAPSS: the global anti-phospholipid syndrome score. Rheumatol (Oxford) 2013;52:1397–403.
11. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. The global anti-phospholipid syndrome score in primary APS. Rheumatology (Oxford) 2015;54:134–8.
12. Sciascia S, Radin M, Sanna G, Cecchi I, Roccatello D, Bertolaccini ML. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis. Rheumatology 2018;1:661–5.
13. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. The global anti-phospholipid syndrome score in primary APS. Rheumatology 2014;54:134–8.
14. Fernandez Mosteirin N, Saez Comet L, Salvador Osuna C, Calvo Villas JM, Velilla MJ. Independent validation of the adjusted GAPSS: role of thrombotic risk assessment in the real-life setting. Lupus 2017;26:1328–32.
15. Radin M, Schreiber K, Costanzo P, Cecchi I, Roccatello D, Baldovino S, et al. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction. Int J Cardiol 2017;240:72–7.
16. Sciascia S, Cuadrado MJ, Sanna G, Murru V, Roccatello D, Khamashta MA, et al. Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort. Arthritis Care Res (Hoboken) 2014;66:1915–20.
17. Zuo Y, Li C, Karp DRLZ. Clinical and epidemiological correlates of the adjusted global anti-phospholipid syndrome score in a large cohort of Chinese APS patients. Arthritis Rheumatol 2015;67(Suppl 10):2626–7.